Adial Pharmaceuticals News

8-K: Current report

Nov 18 16:05 ET

4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

Nov 18 16:05 ET

3: Initial statement of beneficial ownership of securities-Officer Shah Vinay

Nov 18 16:05 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)

Nov 14 15:47 ET

10-Q: Q3 2024 Earnings Report

Nov 13 16:47 ET

8-K: Current report

Nov 12 16:19 ET

8-K: Current report

Nov 5 08:46 ET

ARS: Annual Report to Security Holders

Sep 30 12:56 ET

DEF 14A: Definitive information statements

Sep 27 17:24 ET

10-Q: Q2 2024 Earnings Report

Aug 13 16:18 ET

10-Q: Q1 2024 Earnings Report

May 14 17:05 ET

8-K: Current report

Apr 26 16:06 ET

424B3: Prospectus

Apr 23 16:06 ET

EFFECT: Others

Apr 22 06:06 ET

424B5: Prospectus

Apr 18 17:33 ET

8-K: Current report

Apr 18 17:32 ET

CORRESP: CORRESP

Apr 17 22:18 ET

UPLOAD: Others

Apr 17 22:16 ET

8-K: Current report

Apr 16 16:42 ET

Adial Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Apr 12 16:28 ET